Case Report: A Durable Response to Camrelizumab and Apatinib Combination Therapy in a Heavily Treated Small Cell Carcinoma of the Ovary, Hypercalcemic Type

Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and highly aggressive malignancy with a poor prognosis. Most patients experience recurrence even after surgery and chemotherapy, and there are no standard treatment options for recurrent disease. Here, we report the case of a 3...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Guiling Li, Yao Jiang
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2022-07-01
Saila:	Frontiers in Oncology
Gaiak:	small cell carcinoma of the ovary hypercalcemic type anti-PD-1 antibody antiangiogenic drug SMARCA4 mutation next-generation sequencing
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fonc.2022.916790/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!